The Sertindole Safety Survey: A retrospective analysis under a named patient use programme in Europe

BACKGROUND: After sertindole's suspension, health authorities established a specific named-patient use (NPU) programme in order to supply sertindole to patients who did not respond to or did not tolerate alternative treatments. This programme provided the possibility of prospectively following...

Descripción completa

Detalles Bibliográficos
Autores principales: Lançon, Christophe, Toumi, Mondher, Sapin, Christophe, Hansen, Karina
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2496904/
https://www.ncbi.nlm.nih.gov/pubmed/18638382
http://dx.doi.org/10.1186/1471-244X-8-57

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2496904/
https://www.ncbi.nlm.nih.gov/pubmed/18638382
http://dx.doi.org/10.1186/1471-244X-8-57

Ejemplares similares